Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do arm catheters pose hidden risks in the ICU?

NCT ID NCT05412108

Knowledge-focused Sponsor: Centre Hospitalier le Mans Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tracks complications from MidLine catheters—tubes placed in a vein in the upper arm—in intensive care patients. Researchers want to see how often serious problems like blood clots or infections occur. The goal is to learn whether these catheters are safe enough to replace central lines, which carry higher risks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors choose safer catheters for ICU patients and reduce serious complications like blood clots and infections.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly improve patient outcomes. Results may not apply to all ICU settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

148 people

The number who actually took part.

Started

Feb 2022

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients admitted to the ICU for whom an indication for placement of a MidLine catheter is identified during their ICU stay

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ICU Hospitalization * Indication for MidLine catheter placement during the stay Exclusion Criteria: * Minor or protected adult * Pregnant woman * Local contraindication to the placement of a CM * Local infection * Venous thrombosis * Existing arteriovenous fistula or vascular network to be protected for a fistula for chronic dialysis * Paralysis of the limb * Need for administration of contraindicated solutions on the peripheral venous route: * Catecholamines: Noradrenaline, adrenaline (dose greater than 0.2µg/kg/min) * Total parenteral nutrition * Glucose solutions at a concentration \>20 * Potassium at a concentration \>0.1mEq/ml * Vesicants * Fluids with pH \<5 or \>9

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Catheter complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Catheter complications

Contacts and locations

Locations

  • Centre Hospitalier Du Mans

    Le Mans, 72000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.